ORIGINAL RESEARCH article

Front. Immunol.

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1589563

This article is part of the Research TopicPANoptosis and its role in T cell-based immunotherapyView all 6 articles

Integrative spatial and single-cell transcriptomics elucidate programmed cell death-driven tumor microenvironment dynamics in hepatocellular carcinoma

Provisionally accepted
Kai  LeiKai Lei1Yutong  ZhaoYutong Zhao1Shumin  LiShumin Li1Jiawei  LiuJiawei Liu2Wenhao  ChenWenhao Chen2Caihong  ZhouCaihong Zhou3Yi  ZhangYi Zhang2Jinmei  TanJinmei Tan4Jian  WuJian Wu1Qi  ZhouQi Zhou1Jiehui  TanJiehui Tan2*
  • 1The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China
  • 2Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
  • 3Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China
  • 4Wuchuan People's Hospital, Zhanjiang, China

The final, formatted version of the article will be published soon.

Purpose: Programmed cell death (PCD) mechanisms play crucial roles in cancer progression and treatment response. This study aims to develop a PCD scores prediction model to evaluate the prognosis of hepatocellular carcinoma (HCC) and elucidate the tumor microenvironment differences.: We analyzed transcriptomic data from 363 HCC patients in the TCGA database and 221 patients in the GEO database to develop a PCD prediction model. Single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics sequencing (STseq) data from HCC patients were analyzed to investigate the tumor microenvironment and functional disparities. The oncogenic role of the key gene UBE2E1 in the model was explored in HCC through various in vitro experiments.Results: Seventeen PCD-related genes were identified as significant prognostic indicators, forming the basis of our PCD prediction model. High-PCD scores correlated with poorer overall survival (OS) and exhibited significant predictive capabilities.scRNA-seq analysis revealed distinct tumor cell characteristics and immune microenvironment differences between high-and low-PCD groups. High-PCD tumors showed increased cell proliferation and malignancy-associated gene expression. T cells in high-PCD patients were more likely to be exhausted, with elevated expression of exhaustion markers. ST-seq data also confirmed these results. Among the genes associated with the PCD prognostic model, UBE2E1 was identified as a key oncogenic marker in HCC.The PCD prediction model effectively predicts prognosis in HCC patients and reveals critical insights into the tumor microenvironment and immune cell exhaustion. This study underscores the potential of PCD-related biomarkers in guiding personalized treatment strategies for HCC.

Keywords: Hepatocellular Carcinoma, programmed cell death, Prediction model, Tumor Microenvironment, Ube2E1

Received: 07 Mar 2025; Accepted: 24 Jun 2025.

Copyright: © 2025 Lei, Zhao, Li, Liu, Chen, Zhou, Zhang, Tan, Wu, Zhou and Tan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jiehui Tan, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.